Skip to main content
Clinical Trials/NCT05875324
NCT05875324
Completed
Not Applicable

The Effect of Virtual Reality on Pain, Kinesiophobia and Function in Total Knee Arthroplasty Patients

Kırklareli University1 site in 1 country21 target enrollmentOctober 13, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Knee Arthropathy
Sponsor
Kırklareli University
Enrollment
21
Locations
1
Primary Endpoint
Kinesiophobia assessed by Tampa Kinesiophobia Scale
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The goal of this clinical trial] is to investigate the effects of virtual reality (VR) in patients undergoing total knee arthroplasty (TKA). The main questions it aims to answer are:

  • Does VR have effects on pain, kinesiophobia, and function during the early rehabilitation period of patients who have undergone TKA
  • Does VR contribute to the success of exercise treatment after TKA

All the patients included in the study were informed about the disease, the goals of post-surgical rehabilitation, the conditions to be considered after TKA and exercises. Sitting on the side of the bed and mobilization in or out of the room with a walker were provided with the postoperative 1st day exercises. The patients were discharged 2.5 days after surgery. The patients in both groups were taught an exercise program for home practice.

In addition to the exercise program, the virtual reality application was applied before the exercises to the VR group. The second evaluation was made 3 days after the end of the treatment in both patient groups.

Researchers compared VR and exercise to see if pain, kinesiophobia, pain catastrophizing, knee range of motion, function, and quality of life had changed.

Registry
clinicaltrials.gov
Start Date
October 13, 2019
End Date
August 10, 2021
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ozan Gür, PT

Research Assistant

Kırklareli University

Eligibility Criteria

Inclusion Criteria

  • Being between the ages of 50 and 70
  • Being female
  • Having received TKA due to being at stage III or IV according to the Kellgren-Lawrence Osteoarthritis Classification
  • Having sufficient eyesight
  • Having kinesiophobia and pain catastrophizing

Exclusion Criteria

  • Having undergone bilateral knee arthroplasty/revision knee arthroplasty
  • Vertigo or motion-sensitive nausea
  • Being diagnosed with an additional neurological, rheumatological, or oncological disease
  • Having a Mini Mental Test score of less than 24
  • Being diagnosed with severe anxiety by a specialist physician
  • Inability to complete the treatment program

Outcomes

Primary Outcomes

Kinesiophobia assessed by Tampa Kinesiophobia Scale

Time Frame: 4th week after TKA

Kinesiophobia was evaluated by using the Tampa Kinesiophobia Scale (total score between 17-68) (higher values indicate higher kinesiophobia). The Tampa Kinesiophobia Scale includes the parameters of injury/re-injury and fear of movement; scores of 37 and above indicate the presence of high kinesiophobia (ICC: 0,806).

Secondary Outcomes

  • knee pain assessed by Numerical Pain Rating Scale(4th week after TKA)
  • knee range of motion assessed by universal goniometer(4th week after TKA)
  • subjective functional measurement assessed by Western Ontario and McMaster Universities Osteoarthritis Index(4th week after TKA)
  • quality of life assessed by Short Form 36(4th week after TKA)
  • pain catastrophizing assessed by Pain Catastrophizing Scale(4th week after TKA)
  • objective functional measurement assessed by functional tests(4th week after TKA)

Study Sites (1)

Loading locations...

Similar Trials